logo

For the Inventor, By the Inventor

Montpellier, France

Frederique Haudricourt

This inventor holds 1 USPTO granted patent. Top assignee: Elf Sanofi, a French Corp.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederique Haudricourt. Retrieved from https://idiyas.com/inventor/frederique-haudricourt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Elf Sanofi, a French Corp.
 patent

Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents
1. 5274104 - N-substituted heterocyclic derivatives useful in the treatment of (1993-12-28),

Title: Frederique Haudricourt: Innovator in Cardiovascular Treatment

Introduction

Frederique Haudricourt is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of cardiovascular disorders. His innovative work has led to the development of valuable compounds that can potentially improve patient outcomes.

Latest Patents

Haudricourt holds 1 patent for his invention titled "N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders." This patent describes non-peptide compounds that oppose the action of angiotensin II, which is crucial in managing conditions such as hypertension and heart failure. The compounds are designed to provide therapeutic benefits in treating these serious health issues.

Career Highlights

Frederique Haudricourt has been associated with Elf Sanofi, a prominent French corporation. His work at this company has allowed him to focus on innovative research and development in the pharmaceutical sector. His dedication to improving cardiovascular health through scientific advancements is commendable.

Collaborations

Throughout his career, Haudricourt has collaborated with esteemed colleagues, including Joelle Arnaud and Jean-Louis Assens. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Frederique Haudricourt's contributions to the field of cardiovascular treatment through his innovative patents highlight his role as a significant inventor. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…